CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
Joan Bladé, Diana Samson, Donna Reece, Jane F. Apperley, B. Björkstrand, Gösta Gahrton, Morie A. Gertz, Sergio Giralt, SUNDARr Jagannath, David H. Vesole
British Journal of Haematology, 1998
Abstract
This research paper explore the methodology and findings associated with British Journal of Haematology. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).
- JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM) 2019
- JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-2. Related disorders of multiple myeloma 2019
- Double Autologous Stem Cell Transplantation in a Case of Non-secretory Multiple Myeloma 2016
- Experience in Autologous Stem Cell Transplantation in Elderly Multiple Myeloma Patients 2018
- Autologous and Allogenic Stem Cell Transplantation Results in Multiple Myeloma Patients – Single Center Study 2012
- Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple Myeloma 1997
- Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation 1993
- A Controlled Trial of Urethane Treatment in Multiple Myeloma 1966
- Autotransplants in multiple myeloma: what have we learned? 1996
- Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors. 1993